Current position:Home >Product >
(21E)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8,21-trimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphatricos-21-en-23-oic acid 3,5-dioxide (non-preferred name)
(21E)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8,21-trimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphatricos-21-en-23-oic acid 3,5-dioxide (non-preferred name)(9024-24-2)
- Name: (21E)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8,21-trimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphatricos-21-en-23-oic acid 3,5-dioxide (non-preferred name)
- Synonyms:
- Molecular Formula:C27H42N7O19P3S
- Molecular Weight:893.6442
- CAS Registry Number:9024-24-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 4599-94-4/13H-dibenzo[a,h]fluoren-13-one
- 52656-19-6/1,3-Benzenedicarboxylic acid,polymers,polymer with 1,4-benzenedicarboxylic acid,1,2-ethanediol,hexanedioic acid and 1,6-hexanediol
- 60062-45-5/(1S,5R,11R,14R,17S,20S,21R)-5-methyl-15-methylidene-7-oxa-10-azaheptacyclo[12.6.2.0~1,11~.0~5,20~.0~6,10~.0~12,17~.0~17,21~]docosane-19,22-dione (non-preferred name)
- 67763-97-7/IGF-II
- 114824-90-7/2-(3-hydroxy-2-pyridinyl)-4(1H)-quinazolinone
- 101758-79-6/(3aR)-3,3aβ,4,5,6,6aβ-Hexahydro-5α-hydroxy-4β-[(1E,3S)-3-hydroxy-3-(4α-propylcyclohexan-1α-yl)-1-propenyl]cyclopenta[b]pyrrole-2-pentanoic acid methyl ester
- 194474-46-9/Cirensenoside P
- 18420-46-7/Decanedioic acid, bis(2-methylpropyl) ester
- 7064-35-9/5-(4-METHYLPHENYL)ISOXAZOLE
- 56625-58-2/1-amino-2-[(octyloxy)methyl]anthracene-9,10-dione
- 57853-97-1/EP 794
- 118446-32-5/Asperdurin
- 25188-19-6/1,4-Dioxaspiro[4.4]nonane-6-propanoicacid
- 72403-47-5/Nonylphenol, salicylic acid, formaldehyde polymer, barium salt
- 5374-55-0/1,4-Benzenedicarboxamide, N,N-bis[4- (4, 5-dihydro-1H-imidazol-2-yl)phenyl]-,diformate
- 4922-55-8/N-[p-(1H-1,2,4-Triazol-5-yl)phenyl]succinamidic acid
- 30362-65-3/2,4-bis(4-chlorophenyl)-6-(trichloromethyl)-1,3,5-triazine
- 137376-71-7/5,6-Diethoxy-2-((dimethylamino)methyl)-2,3-dihydro-1H-inden-1-one hydr ochloride
- 9024-24-2/(21E)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8,21-trimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphatricos-21-en-23-oic acid 3,5-dioxide (non-preferred name)
- 126050-30-4/Nonanoic acid, compd. with 2-aminoethanol (1:1)
- 105124-36-5/(4aS,11bS)-9-methoxy-2,3,4,4a,5,6,7,11b-octahydrobenzo[6,7]cyclohepta[1,2-b][1,4]oxazine
- 40067-41-2/N-(4-amino-6-chloropyrimidin-5-yl)-N-cyclopentylformamide
- 84348-14-1/2-methyl-3-[(trimethylsilyl)oxy]cyclopent-2-en-1-one
- 197389-17-6/Kaur-16-en-6-one,3,7,11,15-tetrakis- (acetyloxy)-,(3â,7â,11â,15â)-
- 85763-54-8/Tallow, hydrogenated, aminolysis products with N-(2-aminomethylethyl)-1,2-propanediamine, glycolates
- 7230-69-5/5-(2-ammonio-2-carboxyethyl)-1H-imidazol-3-ium
- 53171-11-2/Isogentiakochianoside
- 69766-44-5/6-nitro-2-(3-piperidin-1-ylpropyl)-1H-benzimidazole hydrochloride hydrate
- 84896-44-6/diisotridecyl 3,3'-[(dibutylstannylene)bis(thio)]dipropionate
- 112270-45-8/5-(7-{4-[(4S)-4-butyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-3-methylisoxazole